Literature DB >> 2049107

Non-phagocytic uptake of intravenously injected microspheres in rat spleen: influence of particle size and hydrophilic coating.

S M Moghimi1, C J Porter, I S Muir, L Illum, S S Davis.   

Abstract

A recent development in prolonging the circulation time of drug carriers, such as liposomes and microspheres, has been to minimize their removal by macrophages of the reticuloendothelial system by covering their surface with hydrophilic polymers such as poloxamers, poloxamines and poly(ethyleneglycols). Here we demonstrate that this strategy may not necessarily prolong the circulatory half-life of drug carriers in all animal models. In rats, as opposed to rabbits, a non-phagocytic mechanism in the spleen may be triggered to remove efficiently from the blood drug carriers coated with hydrophilic coatings. Both the size of particle and its hydrophilic coating may act synergistically to trigger this non-phagocytic mechanism. In rats, a remarkable log to log relationship between particle size and spleen uptake was observed for both uncoated and polymeric coated microspheres. The potential implication of these observations in site-specific delivery of drug carriers is discussed.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2049107     DOI: 10.1016/0006-291x(91)91869-e

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  42 in total

1.  Geometry and surface characteristics of gold nanoparticles influence their biodistribution and uptake by macrophages.

Authors:  M M Janát-Amsbury; A Ray; C M Peterson; H Ghandehari
Journal:  Eur J Pharm Biopharm       Date:  2010-11-18       Impact factor: 5.571

Review 2.  Nanomedicinal strategies to treat multidrug-resistant tumors: current progress.

Authors:  Xiaowei Dong; Russell J Mumper
Journal:  Nanomedicine (Lond)       Date:  2010-06       Impact factor: 5.307

3.  Suppression of agglomeration of ciprofloxacin-loaded human serum albumin nanoparticles.

Authors:  P Vijayaraj Kumar; Narendr K Jain
Journal:  AAPS PharmSciTech       Date:  2007-03-02       Impact factor: 3.246

4.  How stealthy are PEG-PLA nanoparticles? An NIR in vivo study combined with detailed size measurements.

Authors:  Andreas Schädlich; Cornelia Rose; Judith Kuntsche; Henrike Caysa; Thomas Mueller; Achim Göpferich; Karsten Mäder
Journal:  Pharm Res       Date:  2011-04-27       Impact factor: 4.200

5.  Activation of the mononuclear phagocyte system by poloxamine 908: its implications for targeted drug delivery.

Authors:  T I Armstrong; S M Moghimi; S S Davis; L Illum
Journal:  Pharm Res       Date:  1997-11       Impact factor: 4.200

6.  Splenic trapping of nanoparticles: complementary approaches for in situ studies.

Authors:  M Demoy; S Gibaud; J P Andreux; C Weingarten; B Gouritin; P Couvreur
Journal:  Pharm Res       Date:  1997-04       Impact factor: 4.200

7.  Shape mediated splenotropic delivery of buparvaquone loaded solid lipid nanoparticles.

Authors:  Heena V Maithania; Bhabani S Mohanty; Pradip R Chaudhari; Abdul Samad; Padma V Devarajan
Journal:  Drug Deliv Transl Res       Date:  2020-02       Impact factor: 4.617

8.  Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery.

Authors:  Jianjun Cheng; Benjamin A Teply; Ines Sherifi; Josephine Sung; Gaurav Luther; Frank X Gu; Etgar Levy-Nissenbaum; Aleksandar F Radovic-Moreno; Robert Langer; Omid C Farokhzad
Journal:  Biomaterials       Date:  2006-10-20       Impact factor: 12.479

9.  Development of high drug loaded and customizing novel nanoparticles for modulated and controlled release of Paclitaxel.

Authors:  Primiano Pio Di Mauro; Salvador Borrós
Journal:  Pharm Res       Date:  2014-06-18       Impact factor: 4.200

Review 10.  Nanogels: An overview of properties, biomedical applications and obstacles to clinical translation.

Authors:  Kruti S Soni; Swapnil S Desale; Tatiana K Bronich
Journal:  J Control Release       Date:  2015-11-10       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.